THRIVENT HEALTHCARE PORTFOLIO is a registered fund series of Thrivent Series Fund, Inc. (series S000021867). Net assets $222.5M as of 2026-03-31.
Showing 15 of 46 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| ELI LILLY AND COMPANY | — | $29.2M | 1312.00% |
| JOHNSON & JOHNSON | — | $21.1M | 948.56% |
| ABBVIE INC | — | $15.3M | 689.12% |
| MERCK & CO INC | — | $12.3M | 554.01% |
| UNITEDHEALTH GROUP INC | — | $11.1M | 499.29% |
| STRYKER CORPORATION | — | $8.3M | 375.15% |
| DANAHER CORPORATION | — | $7.6M | 341.11% |
| AMGEN INC | — | $7.2M | 321.94% |
| ABBOTT LABORATORIES | — | $6.5M | 291.09% |
| GILEAD SCIENCES INC | — | $6.1M | 274.13% |
| PFIZER INC | — | $5.6M | 249.51% |
| INTUITIVE SURGICAL INC | — | $5.4M | 243.85% |
| MEDTRONIC PLC | — | $5.3M | 237.08% |
| BRISTOL-MYERS SQUIBB CO | — | $5.2M | 233.45% |
| CENCORA INC | — | $5.0M | 224.03% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $222.5M |
| 2025-12-31 | $244.9M |
| 2025-09-30 | $236.3M |
| 2025-06-30 | $233.4M |
| 2025-03-31 | $254.6M |
| 2024-12-31 | $248.2M |
| 2024-09-30 | $282.0M |
| 2024-06-28 | $277.0M |